References
- Baier G, Baumann D, Siebert JM, et al. (2012). Suppressing unspecific cell uptake for targeted delivery using hydroxyethyl starch nanocapsules. Biomacromolecules 13:2704–15
- Bhatt R, Vries P, Tulinsky J, et al. (2003). Synthesis and in vivo antitumor activity of poly(L-glutamic acid) conjugates of 20(S)-camptothecin. J Med Chem 46:190–3
- Botella P, Abasolo I, Fernandez Y, et al. (2011). Surface-modified silica nanoparticles for tumor-targeted delivery of camptothecin and its biological evaluation. J Controlled Release 156:246–57
- Burke GT, Mi Z. (1994). The structural basis of camptothecin interactions with human serum albumin: impact on drug stability. J Med Chem 37:40–6
- Cheng JJ, Khin KT, Davis ME. (2004). Antitumor activity of β-cyclodextrin polymer-camptothecin conjugates. Mol Pharm 3:183–93
- Cheng JJ, Khin KT, Jensen GS, et al. (2003). Synthesis of linear, β-cyclodextrin-based polymers and their camptothecin conjugates. Bioconjug Chem 14:1007–17
- Deshmukh M, Chao P, Kutscher HL, et al. (2010). A series of α-amino acid ester prodrugs of camptothecin: in vitro hydrolysis and A549 human lung carcinoma cell cytotoxicity. J Med Chem 53:1038–47
- Fleming AB, Haverstick K, Saltzman WM. (2004). In vitro cytotoxicity and in vivo distribution after direct delivery of PEG-camptothecin conjugates to the rat brain. Bioconjug Chem 15:1364–75
- Joralemon MJ, McRae S, Emrick T. (2010). PEGylated polymers for medicine: from conjugation to self-assembled systems. Chem Commun 46:1377–93
- Lerchen HG, Baumgarten J, Bruch K, et al. (2001). Design and optimization of 20-O-linked camptothecin glycoconjugates as anticancer agents. J Med Chem 44:4186–95
- Li C, Wallace S. (2008). Polymer-drug conjugates: recent development in clinical oncology. Adv Drug Deliv Rev 60:886–98
- Li G, Cai C, Ren T, Tang X. (2014). Development and application of a UPLC-MS/MS method for the pharmacokinetic study of 10-hydroxy camptothecin and hydroxyethyl starch conjugate in rats. J Pharm Biomed Anal 88:345–53
- Lorence A, Nessler CL. (2004). Camptothecin, over four decades of surprising findings. Phytochemistry 65:2735–49
- Maeda H, Bharate GY, Daruwalla J. (2009). Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm 71:409–19
- Mendichi R, Rizzo V, Gigli M, Schieroni AG. (2002). Fractionation and characterization of a conjugate between a polymeric drug-carrier and the antitumor drug camptothecin. Bioconjug Chem 13:1253–8
- Noga M, Edinger D, Klager R, et al. (2013). The effect of molar mass and degree of hydroxyethylation on the controlled shielding and deshielding of hydroxyethyl starch-coated polyplexes. Biomaterials 34:2530–8
- Noga M, Edinger D, Rodl W, et al. (2012). Controlled shielding and deshielding of gene delivery polyplexes using hydroxyethyl starch (HES) and alpha-amylase. J Controlled Release 159:92–103
- Rozet E, Marini RD, Ziemons E, et al. (2011). Advances in validation, risk and uncertainty assessment of bioanalytical methods. J Pharm Biomed Anal 55:848–58
- Samor C, Guerrini A, Varchi G, et al. (2008). The role of polyamine architecture on the pharmacological activity of open lactone camptothecin-polyamine conjugates. Bioconjug Chem 19:2270–9
- Subramanian N, Sundaraganesan N, Sudha S, et al. (2011). Experimental and theoretical investigation of the molecular and electronic structure of anticancer drug camptothecin. Spectrochim Acta Part A 78:1058–67
- Tong R, Cheng JJ. (2010). Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates. Bioconjug Chem 21:111–21
- Torchilin V. (2011). Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 63:131–5
- Venditto VJ, Simanek EE. (2010). Cancer therapies utilizing the camptothecins: a review of the in vivo literature. Mol Pharm 7:307–49
- Zhang H, Wang J, Mao W, et al. (2013). Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: in vitro and in vivo studies. J Controlled Release 166:147–58
- Zhao H, Rubio B, Sapra P, et al. (2008). Novel prodrugs of SN38 using multiarm poly(ethylene glycol) linkers. Bioconjug Chem 19:849–59